Loss of the tumor suppressor phosphatase and tensin homolog (PTEN) has frequently been observed in human gliomas, conferring AKT activation and resistance to ionizing radiation (IR) and drug treatments. Recent reports have shown that PTEN loss or AKT activation induces premature senescence, but many details regarding this effect remain obscure. In this study, we tested whether the status of PTEN determined fate of the cell by examining PTEN-deficient U87, U251, and U373, and PTEN-proficient LN18 and LN428 glioma cells after exposure to IR. These cells exhibited different cellular responses, senescence or apoptosis, depending on the PTEN status. We further observed that PTEN-deficient U87 cells with high levels of both AKT activation and intracellular reactive oxygen species (ROS) underwent senescence, whereas PTEN-proficient LN18 cells entered apoptosis. ROS were indispensable for inducing senescence in PTEN-deficient cells, but not for apoptosis in PTENproficient cells. Furthermore, transfection with wild-type (wt) PTEN or AKT small interfering RNA induced a change from premature senescence to apoptosis and depletion of p53 or p21 prevented IR-induced premature senescence in U87 cells. Our data indicate that PTEN acts as a pivotal determinant of cell fate, regarding senescence and apoptosis in IR-exposed glioma cells. We conclude that premature senescence could have a compensatory role for apoptosis in the absence of the tumor suppressor PTEN through the AKT/ROS/p53/p21 signaling pathway.
Gliomas are the most common type of brain tumor, and grade IV glioblastomas are almost universally fatal. Treatment of glioblastomas typically involves surgical resection in combination with radiation and alkylating agent-based adjuvant chemotherapy. However, even in instances in which complete surgical resection of theses tumors is possible, the tumor generally recurs within a year, regardless of its initial response to treatment. 1 Oncogenes (EGF, PDGF, and their receptors) and tumor suppressor genes (p16 INK4a , p14 ARF , PTEN, RB1, and TP53) are involved in the evolution of glioblastomas, 2 and activation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway has a crucial role in their development. 3 The tumor suppressor gene PTEN encodes a lipid phosphatase that counteracts the effect of PI3K signaling, thereby negatively controlling the activation of this pathway. Tumor suppressor PTEN is mutationally and transcriptionally inactivated in many different tumor types, including glioblastoma. 3 A central node in signaling events downstream of PI3K is controlled by the serine-threonine kinase AKT. Therefore, AKT is activated by PI3K, which generates phosphatidylinositol 3, 4, 5-trisphosphate, and is negatively regulated by phospholipid phosphatases PTEN. 4 Hyperactivated AKT provides protection from apoptosis and promotes uncontrolled cell cycle progression. 5 However, it has recently been shown that AKT activity increases with cellular senescence, and that inhibition of AKT extends the lifespan of primary cultured human endothelial cells. 6 Cellular senescence is an extremely stable form of cell cycle arrest, which is activated in response to stress, including oncogenic signaling and telomere shortening. 7 The initial description of cellular senescence by Hayflick and Moorehead was based on the endurable analysis of normal human cells grown in vitro. 8 In contrast to cancer cells, they observed that normal cells had a finite proliferative capacity that ended in stable and long-term cell cycle arrest. Considering that neoplastic transformation involves events that inhibit the program of senescence, tumor cells were believed to have lost the ability to senescence. However, recent data has shown that tumor cells can be readily induced to undergo senescence by genetic manipulation, or by treatment with chemotherapeutic drugs, radiation, or differentiation agents. 9 The importance of cellular senescence is increasingly being recognized as a tumor suppression mechanism. 10, 11 Here, we show that after ionizing radiation (IR) exposure, PTEN acts as a critical determinant of cell fate between senescence and apoptosis in the glioma cell lines U87, U251, U373, LN18, and LN428. The U87, U252, and U373 cells underwent senescence by p21 induction because of mutation or deficiency of PTEN. However, LN428 and LN18 cells, which express wild-type (wt) PTEN, displayed apoptotic, as opposed to senescent, phenotypes after IR exposure. Further examinations suggest that premature senescence could be an alternative mechanism to prevent aberrant cell proliferation, instead of apoptosis, in the absence of the tumor suppressor PTEN.
Results
PTEN status dictates premature senescent and apoptotic phenotypes in glioma cells following IR exposure. To test whether the cellular response of glioma to IR is associated with PTEN status, we exposed several glioma cell lines, including PTEN-deficient U87, U251, and U373 and the PTEN-proficient LN18 and LN428 cells to various doses of IR. We first examined relative cell numbers and cellular morphologies, and observed that all cell types had decreased cell numbers in a dose-dependent manner following IR (Figure 1a) . Furthermore, microscopic analyses indicated that U87, U251, and U373 cells were positive for senescence-associated b-galactosidase (SA-b-Gal), a hallmark of senescence, and for senescent morphology (large flattened shape) (Figure 1b) . In contrast, LN18 and LN428 cells became susceptible to trypan blue staining, and displayed Annexin V positivity, in a dose-dependent manner (Figure 1c) . Cyclin-dependent kinase inhibitor p21, one of senescence markers, was dramatically increased in PTEN-deficient U87, U251, and U373 cells, but not in PTEN-proficient LN18 and LN428 cells, and cleaved poly (ADP-ribose) polymerase (PARP), which is an indicator of the biochemical changes due to caspase activation during apoptosis was detected only in LN18 and LN428 cells Significantly different: *Po0.01 versus control (C) or C at indicated days. mt, mutant; wt, wild type ( Figure 1d ). Caspase-3/7 activity and pro-caspase 3 cleavage were also increased in dose-and time-dependent manners to exposure to IR in LN18 and LN428 cells (Supplementary Figure S1 ). These data suggest that decreased cell numbers after exposure to IR are due to premature senescence in PTEN-deficient cells, and due to apoptosis in PTEN-proficient cells, regardless of p53 status. In PTEN-deficient PC-3 and PTEN-proficient DU145 prostate cancer cells, we observed cellular responses to IR that were very similar to those in glioma (Supplementary Figure S2) . (Figure 2c and d) , whereas PTEN-proficient LN18 and LN428 cells underwent apoptosis, regardless of stimulus type (Figure 2a-d) . Levels of p21 increased after administration of high doses of IR, but not in doxorubicin-treated U87, U251, and U373 cells, and neither treatment induced p21 expression in LN18 nor LN428 cells (Figure 2d ). We could not detect expression of other cell cycle regulatory proteins such as p16 and p14 (data not shown), consistent with prior data showing they are deleted in all glioma cell lines used in this study except U373. 12 Cleaved PARP was observed in doxorubicin-treated U87, U251, and U373 cells and in LN18 and LN428 cells treated with high doses of IR or doxorubicin. Caspase-3/7 activity and pro-caspase 3 cleavage were detected in doxorubicintreated U87, U251, U373, LN18, and LN428 cells (Supplementary Figure S3 ). In contrast with the response to IR, these data demonstrate that PTEN-deficient cells underwent apoptosis, not senescence, as a result of doxorubicin treatment. This indicates that PTEN-deficient cells could activate either apoptosis or senescence pathways, depending on the type of cellular stimulus. When we applied hydrogen peroxide (H 2 O 2 ) to U87 and LN18 cells to examine cellular responses to other stimuli in the presence or the absence of PTEN, LN18 cells showed dramatic increases in the number of trypan blue positive cells and PARP cleavage, and no induction of p21, as compared with U87 cells (Supplementary Figure S4) .
Reactive oxygen species are essential for the induction of senescence in U87 cells, but not for apoptosis in LN18 cells. We next examined molecular changes of senescence in PTEN-deficient U87 cells, and those of apoptosis in PTEN-proficient LN18 cells, over time following IR treatment. Both cell types had an immediate reduction in cell number and in morphological changes, and as before, only U87 cells had increased SA-b-Gal staining ( Figure 3a) . Furthermore, the increase in apoptotic cells, which was detected using Annexin V assay, was evidently observed in LN18 cells (Figure 3b ), as we previously observed. As shown in Figure 3c , LN18 cells exhibited dramatic increases in PTEN, mutant p53, and cleaved PARP. However, phospho-AKT (S473) and p21 induction were not detected. In contrast, U87 cells were characterized by gradual increases in phospho-AKT, wt p53, and p21 ( Figure 3c ). There were no detectable PARP cleavage and PTEN induction in U87 cells.
We tested for reactive oxygen species (ROS) production in U87 and LN18 cells to know whether there was difference in the levels of ROS between premature senescence and apoptosis. Reactive oxygen species increased in both cell lines, and U87 cells exhibited significantly higher intracellular ROS levels than LN18 cells (Figure 3d , left panel). As it has been known that active AKT could reduce MnSOD and catalase expression by inhibition of Forkhead box O 1/3 (FOXO1/3), 5 and AKT activation was detected in U87 cells after IR exposure in this study, we next tested for levels of phospho-FOXO1/3, MnSOD, and catalase. We observed no effect of IR on FOXO1/3 phosphorylation or levels of MnSOD, Cu/ZnSOD, or catalase in U87 and LN18 glioma ( Figure 3d , middle panel), indicating that increased ROS levels were not attributed to FOXO1/3 phosphorylation or the decrease of antioxidant enzymes in either of the cell lines. As mitochondrial ROS are the major source of intracellular ROS, we next measured fluorescence of MitoSOX Red as a mitochondrial superoxide indicator (Figure 3d , right panel). Fluorescence intensity of MitoSOX Red was increased in both the cell lines and more significantly in U87 cells, consistent with increased intracellular ROS levels.
To verify the role of ROS in senescence or apoptosis induced by IR, we treated U87 and LN18 cells with the ROS scavenger N-acetyl-l-cysteine (NAC) before IR exposure (Figure 4a ). Whereas NAC blocked induction of senescence in U87 cells, it did not inhibit apoptotic cell death in LN18 cells (Figure 4b-d) . Relative cell numbers were decreased both in IR-treated and in NAC and IR co-treated LN18 cells (Figure 4b ), and the percentage of apoptotic cells and PARP cleavage were not recovered by treatment of LN18 cells with NAC (Figure 4c and d) . Likewise, we observed no increase in SA-b-Gal activity and p21 induction in LN18 cells (Figure 4c and d). In contrast, pretreatment of U87 cells with NAC before exposure to IR, reduced SA-b-Gal staining, wt p53 activation, and p21 induction, which had been induced by IR exposure (Figure 4c and d) . However, AKT activation and PARP cleavage were not affected here (Figure 4d ), and total cell number and percentage of apoptotic cells were not increased (Figure 4b and c) . Together, these data suggest that ROS generation, likely through the upstream AKT and the downstream p53/p21 signaling pathways, is indispensable for the induction of senescence phenotypes, but not apoptosis, in glioma.
Wild-type PTEN expression or AKT depletion shifts premature senescence to apoptosis in IR-exposed U87 glioma. We clarified the role of PTEN/AKT in cellular senescence by transfecting either wt PTEN or AKT small interfering RNA (siRNA) into U87 cells. Overall, we observed that transfection of either wt PTEN or AKT siRNA induced apoptosis instead of senescence as responses to IR exposure. Increases in SA-b-Gal activity and intracellular ROS levels, which were because of IR exposure, were reduced by wt PTEN expression (Figure 5a , right panel, and c). Annexin V-positive cells and caspase-3/7 activity were increased, and cleaved PARP was detected instead of p21 induction (Figure 5b and d) . The p53/p21 signaling pathway is essential for the induction of IR-induced senescent phenotypes in U87 cells. We next tested if IR-induced senescence requires signaling of the p53/p21 pathway in U87 cells. We transfected siRNA specific for p53 into U87 cells expressing wt p53, and looked for senescent phenotypes (Figure 7) . In p53 siRNA transfected cells before IR exposure, p21 expression was not induced (Figure 7c) , and cells showed decreased SA-b-Gal activity (Figure 7a, right panel) . When we examined whether the absence of p53 could trigger apoptosis instead of senescence, increased apoptotic cells, caspase-3/7 activity, and PARP cleavage were not detected ( Figure   7b and c). Furthermore, increases in intracellular ROS and mitochondrial superoxide, which were observed in U87 cells after IR exposure, were not affected in p53 siRNAtransfected cells (Figure 7d , left and middle panels). Decrease in S-phase entry, which was detected using bromodeoxyuridine (BrdU) incorporation assay, was not reverted in p53 siRNA-transfected cells (Figure 7d (Figure 8a , middle and right panels). Likewise, evidence of apoptosis was not detected after p21-siRNA transfection, such as increases in apoptotic cell, caspase-3/7 activity, and PARP cleavage (Figure 8b and c) . Finally, increase in intracellular ROS level originated from mitochondria and cell cycle arrest were not returned to control levels (Figure 8d ). These data suggest that depletion of either p53 or p21 directs PTEN-deficient U87 cells towards cytostatic (that is, cell cycle arrest) characteristics, rather than to apoptosis. When we analyzed cell cycle distribution, p53-or p21-depleted cells exhibited increases in aneuploid cells (44N) (data not shown), which has been reported as a cause of cytostasis. 13, 14 Altogether, the p53/p21 signaling pathway is critical for the induction of senescent phenotypes by IR exposure in PTEN-deficient U87 glioma.
As we detected increases in another cell cycle inhibitor p27 in both p53 siRNA-and p21 siRNA-transfected cells ( Figure  7c and 8c) , we next co-transfected cells with p27 siRNA and either p21 siRNA or p53 siRNA to examine the role of p27 in such cytostatic state. Transfection with p27 siRNA did not affect the cytostatic status of p53 siRNA-or p21 siRNAtransfected cells (Figure 8e ). This could be because of additional roles of PTEN, independent of AKT, such as protein phosphatase activity. 15 The mechanism regarding the cytostatic status in p53-and p21-depleted cells needs to be clarified by further experiments.
Discussion
Senescent cells are characterized by irreversible cell cycle arrest, although they remain metabolically active and acquire specific properties, such as large and flattened morphological changes, SA-b-Gal staining based on lysosomal b-galactosidase activity at pH 6.0, resistance to apoptosis, and altered gene expression. 16 More than 50 years after Hayflick and Moorehead reported replicative senescence in normal human fibroblasts, recent evidence has suggested that cellular senescence is a defense mechanism against tumorigenesis in vivo. 17 In addition, as cellular senescence is abundant in premalignant neoplastic lesions and tumor regression is attributed to cellular senescence, this process is considered to have a crucial role in tumor treatment. 18, 19 Indeed, if cellular senescence pathways remain intact, senescence induction could compensate for the inactivation of the apoptotic pathway and could be triggered with low doses of chemotherapeutic drugs or IR. 20 Therefore, it is possible that improved tumor treatments could be developed by understanding the mechanism of premature senescence. 9 Gliomas are the most common malignant brain tumor in adults and are among the most lethal of all cancers. 21, 22 Glioblastomas contain a number of clearly defined genetic lesions, which result in disruption of critical cellular signaling pathways that regulate cell proliferation. Activation of the AKT oncogene by mutational inactivation of the PTEN tumor suppressor, or mutational activation of PI3K, is common in glioblastomas. 23 As these genetic lesions regulate biological and clinical behaviors of tumor cells, the resultant disrupted signaling pathways represent attractive targets for therapy. 24 The aim of this study was to elucidate whether PTEN status could alter cellular responses to IR using five different glioma cell lines. We found that PTEN-deficient U87, U373, and U252 glioma cells, which have an active AKT signaling pathway because of the absence of PTEN, entered senescence following IR exposure. However, the PTEN-proficient cell lines LN428 and LN18 underwent apoptosis under the same treatment conditions. AKT has crucial roles not only in the proliferation and survival of mammalian cells, thereby promoting tumorigenesis, but also for the induction of premature senescence. 6, 25 In this study, U87 cells depleted of either p53 or p21 did not develop a senescent phenotype, but instead remained cytostatic as opposed to triggering apoptosis in response to activated AKT. 26, 27 In addition, acute PTEN inactivation induces growth arrest through the p53-dependent cellular senescence pathway both in vitro and in vivo.
28 PTEN/AKT might exert another regulatory function(s) of cell proliferation through a p53/p21-independent pathway. For example, as PTEN has recently been reported to have protein phosphatase activity in addition to lipid phosphatase activity, 15 PTEN may have additional roles in tumor biology, independent of AKT activity and the senescence pathway. As we found that p27, another cell cycle inhibitor, did not have a role in the cytostatic status of p53-and p21-depleted cells, additional experiments will need to be performed before the details regarding this mechanism are understood.
Although the PI3K/AKT pathway is involved in both premature senescence and cell proliferation, the specific mechanism related to this process is not fully understood. Here, we observed that different responses by glioma cell lines are dependent on PTEN status, and that PTEN has a critical role in switching cell fate between senescence and apoptosis after IR exposure. We also found that depletion of AKT or scavenging of ROS prevented IR-induced senescence in PTEN-deficient glioma. These data suggest that the effect of PTEN on cellular senescence is likely mediated by increased intracellular ROS by AKT activation. Since the discovery that H 2 O 2 can induce apoptosis, many reports have demonstrated the importance of ROS in the apoptotic pathway in various cell systems. 29, 30 However, it has also been reported that significant levels of ROS are produced in senescing cells, but not in apoptotic cells. 31 Similar studies have shown that ROS are also produced in cells undergoing apoptotic-like cell death, but that the produced ROS do not cause apoptosis. 32 In this study, we observed that ROS were not required to induce apoptosis in PTEN-proficient glioma.
Recent reports suggested that constitutive activation of AKT promotes senescence-like arrest of cell growth through inhibition of the transcription factor FOXO1/3.
6,33
Inhibition of FOXO1/3 increases intracellular ROS through the regulation of antioxidant enzymes levels, such as MnSOD, sestrin, and catalase, and many experiments have shown that ROS have a critical role in determining life span and cellular senescence in mammalian cells. 5 In this study, ROS levels were elevated during IR-induced senescence, and the ROS scavenger NAC reverted IR-induced senescence phenotypes, including p53 activation, p21 induction, and SA-b-Gal activity. However, increases in intracellular ROS levels were not attributed to the phosphorylation of FOXO1/3 through AKT activation.
Radiotherapy (RT) is one of major regimes for cancer therapy, and research in radiation biology is currently focused on identifying more effective means to increase RT efficacy. 34 It is accepted that apoptosis has a primary role in tumor regression after RT, and many studies have attempted to elucidate applicable mechanisms to increase cells undergoing apoptosis in RT-targeted tumors. 35, 36 It has been known that apoptosis is readily induced in tumors derived from hematopoietic, lymphoid, and germ cells, but some solid tumors derived from epithelial cells show resistance to apoptosis after IR exposure. 37, 38 Recent evidence has shown that IR prematurely induces senescent phenotypes, instead of apoptosis, before the Hayflick limit, which is known as stressinduced premature senescence. We also previously reported that IR induces premature senescence in breast, colon, and lung carcinoma, and in tumor tissue of xenografted mice. 20, 39 Therefore, understanding premature senescence mechanisms could provide helpful information for improving the efficacy of RT.
In this study, we describe for the first time a detailed molecular mechanism of IR-induced senescence in PTENdeficient glioma. Premature senescence has a compensatory role in apoptosis in the absence of the tumor suppressor PTEN through the AKT/ROS/p53/p21 pathway, whereas PTEN proficiency sensitizes glioma cells to apoptosis, independently of p53 and ROS (Figure 8f) . Conclusively, our results affirm that RT-induced premature senescence could be an alternative fail-safe treatment option in apoptosisresistant glioma cells, and we expect our findings may aid in the understanding of the clinical significance of premature senescence in PTEN-deficient tumor cells.
Materials and Methods
Materials. LN18 and U87 glioma cell lines were purchased from American Type Culture Collections (Manassas, VA, USA) and U251, U373, and LN428 cell lines were obtained from Prof. S-J Lee in Hanyang University (Seoul, Korea). These cell lines were cultured in Dulbecco's modified Eagle's medium (HyClone, Logan, UT, USA) supplemented with 10% fetal bovine serum (WelGENE, Daegu, Korea) and 25 U/ml penicillin/streptomycin. The p53 antibody was purchased from Novocastra 
